P362: Vasopressin alone and with noradrenaline attenuates TNF-α production in an in-vitro model of monocyte priming and deactivation

Autor: Davies, R, O'Dea, KP, Soni, S, Ward, JK, O'Callaghan, DJP, Takata, M, Gordon, AC

Publikováno v: 37th International Symposium on Intensive Care and Emergency Medicine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1032::81989529ee6d705562eefe689e1c2316
http://hdl.handle.net/10044/1/50174

High-throughput mass spectrometry maps the sepsis plasma proteome and differences in patient response.

Autor: Mi Y; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK., Burnham KL; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK., Charles PD; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK., Heilig R; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK., Vendrell I; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.; Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford OX3 7BN, UK., Whalley J; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK., Torrance HD; Division of Anaesthetics, Pain Medicine and Intensive Care, Imperial College, London SW7 2AZ, UK., Antcliffe DB; Division of Anaesthetics, Pain Medicine and Intensive Care, Imperial College, London SW7 2AZ, UK.; Department of Critical Care, Imperial College Healthcare NHS Trust, London W2 1NY, UK., May SM; Translational Medicine and Therapeutics, William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK., Neville MJ; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford OX3 7LE, UK.; NIHR Oxford Biomedical Research Centre, Oxford OX3 9DU, UK., Berridge G; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK., Hutton P; Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7JX, UK., Geoghegan CG; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK., Radhakrishnan J; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK., Nesvizhskii AI; Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA., Yu F; Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA., Davenport EE; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK., McKechnie S; Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7JX, UK., Davies R; Division of Anaesthetics, Pain Medicine and Intensive Care, Imperial College, London SW7 2AZ, UK., O'Callaghan DJP; Division of Anaesthetics, Pain Medicine and Intensive Care, Imperial College, London SW7 2AZ, UK.; Department of Critical Care, Imperial College Healthcare NHS Trust, London W2 1NY, UK., Patel P; Department of Critical Care, Imperial College Healthcare NHS Trust, London W2 1NY, UK., Del Arroyo AG; Translational Medicine and Therapeutics, William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK., Karpe F; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford OX3 7LE, UK.; NIHR Oxford Biomedical Research Centre, Oxford OX3 9DU, UK., Gordon AC; Division of Anaesthetics, Pain Medicine and Intensive Care, Imperial College, London SW7 2AZ, UK.; Department of Critical Care, Imperial College Healthcare NHS Trust, London W2 1NY, UK., Ackland GL; Translational Medicine and Therapeutics, William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK., Hinds CJ; Translational Medicine and Therapeutics, William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK., Fischer R; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.; Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford OX3 7BN, UK., Knight JC; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.; Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford OX3 7BN, UK.; NIHR Oxford Biomedical Research Centre, Oxford OX3 9DU, UK.

Publikováno v: Science translational medicine [Sci Transl Med] 2024 Jun 05; Vol. 16 (750), pp. eadh0185. Date of Electronic Publication: 2024 Jun 05.